A Study of Auxora in Patients With Critical COVID-19 Pneumonia

Summary

This is a single-blind study of Auxora in patients with critical COVID-19 pneumonia, consisting of up to 3 cohorts of escalating dose. The main goal was to assess pharmacodynamic parameters of immune response, while also assessing safety and tolerability of the drug in this patient population.

Timeline

Start

2021-03-02

Primary completion

2021-12-21

Completion

2021-12-21

Outcome

Outcome not reported

Stopped: “The trial was terminated early due to the limited number of new COVID-19 hospitalizations.”

Drugs

Indications